User Support Reference Group

Page tree

Versions Compared

Old Version 10

changes.mady.by.user Shane Byrnes

Saved on

compared with

New Version 11

changes.mady.by.user Alejandro Lopez Osornio

Saved on

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.


Info
titleMeeting Details

Date & Time: 19th June 2025, 11am UTC


Info
titleObjectives
  • Users' discussions about the SNOMED International Drug Model and National Drug Extension Model.

Attendees:

Linda Bird Karin Drivenes Dion McMurtrie Guillermo Reynoso Michael Keary @ad



Info
titleZoom Link

Link: Zoom Link

Meeting ID: 85802638911

Passcode: 223446


Info
titleMeeting Recording

Link:   https://snomed.zoom.us/rec/share/haDDBYEy_Zp8ry9Gq0aUj-djWHRMJYHCOpIXVR7mmuhfsL6gsK_fXUZK4RTbqv94.mfGCsVRvicjpX0Kc

Passcode: *4F0MCL!


Discussion items                                              

Item

Description

Mins

Owner

Notes & Actions

1Opening2 min

Alejandro Lopez Osornio Shane Byrnes 

Welcome & Notification of Recording

2Hydration Subsumption (incl. less granular Clinical Drug)50 min
@Canada
@All
  • Proposal from Canada
  • Group discussion on options
3Substances Co-Ordination Update8 minAlejandro Lopez Osornio 
  • Combined substances sheet link has been updated: HERE.
  • Update on substances in multiple extensions (circa. 80)
  • Update on substances in single extensions
4AOB


5Topic Backlog

  • Hydration Subsumption
  • Less Granular Clinical Drug
  • Elemental Substances (Matt, AUS)
  • Dose Form Intended Site v Route of Administration (BEL)
  • Substances Co-ordination
    • Step 1: Substances in multiple extensions
    • Step 2: Substances in one extension 
    • Step 3: Ongoing Substance Co-ordination (capturing at regulator level)
  • Medication Stopped v Medication Discontinued (Karen, SI)
  • Medicinal Product promotion co-ordination (Oslo group discussion as linked to substances work)
  • Value range of a |Has container type| attribute (Linda, CA)
  • Drug extension MRCM attributes (CA, AUS)
  • Top level children of 373873005 |Pharmaceutical / biologic product| hierarchy - are members using/how are members using? (AUS) 
  • Group Input on Patch Strength Representation
6




 

Attachments